Content about Specialty Pharmacy

September 28, 2012
FDA approves Abbott's Humira for ulcerative colitis

The Food and Drug Administration has approved a drug made by Abbott for treating ulcerative colitis.

September 28, 2012
Health, industry officials look for ways to combat counterfeit drug spread

Keynote speeches by pharmaceutical industry and regulatory leaders got top billing as more than 140 government, healthcare industry, law enforcement and patient advocacy officials gathered to find ways to combat the spread of counterfeit medicines.

September 28, 2012
OncoGenex starts phase-3 trial of lung cancer drug

Drug maker OncoGenex Pharmaceuticals has started its third late-stage clinical trial of a drug for treating a type of lung cancer.

September 28, 2012
Walgreens is coming out swinging in 2013

2012 was a tough year for Walgreens. The Chicagoland retailer took a stand against a major PBM and took it on the chin. But that entire time, while the company did what it thought was right to protect the value of the services it provides today, Walgreens continued to focus on developing a better retail pharmacy experience with many new product offerings and services that is setting the stage for tomorrow.

September 27, 2012
FDA approves new cancer drug

The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

September 27, 2012
Janssen launches new medical information tool

Janssen Scientific Affairs has debuted an new online scientific resource for U.S. healthcare professionals seeking instant access to current information about Janssen products marketed in the United States.

September 26, 2012
Astellas applies for FDA approval of organ transplant drug

The U.S. subsidiary of Japanese drug maker Astellas is seeking approval from the Food and Drug Administration for a drug to prevent rejection of transplanted organs.

September 26, 2012
Depomed sues FDA over drug for shingles-related pain

A drug maker is suing the Food and Drug Administration to force the agency to give a special designation to one of its drugs.

September 25, 2012
Valeant buys eye drug for $112.5 million

Valeant Pharmaceuticals International has acquired rights to a drug used to treat a symptom of age-related macular degeneration, the drug maker said.

September 25, 2012
Watson recalls two lots of opioid painkiller

Generic drug maker Watson Labs recalled two lots of a prescription painkiller due to the potential for oversized and overly potent tablets, the company said.

September 24, 2012
FDA approves Regeneron drug for macular edema

The Food and Drug Administration has approved a drug for treating a complication of a disease that results from vein blockages in the eye.

September 21, 2012
AmerisourceBergen: Pharmaceuticals business has bright future

The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said at the wholesaler's ThinkLive Manufacturer's Summit.

September 21, 2012
Amgen drug approved for osteoporosis in men

The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

September 21, 2012
Avella named fastest-growing Ariz. company

The Arizona Corporate Excellence Awards has named Avella Specialty Pharmacy as the fastest-growing private company based in the state, Avella said.

September 20, 2012
Educational series from SisterLove, Merck shows 'everyone has a story'

Atlanta-based reproductive and sexual health organization SisterLove and drug maker Merck have collaborated to create a mini-documentary and educational HIV/AIDS treatment and care resource.

September 20, 2012
National Association of Specialty Pharmacy to make debut

A nonprofit organization that will be dedicated to representing all specialty pharmacy stakeholders and providing a voice in the specialty pharmacy industry will make its debut in October.

September 14, 2012
Lundbeck adds Omnicare to limited distribution network for Huntington's drug

The specialty pharmacy operated by Omnicare Specialty Care Group has been added to the limited distribution network for a drug used to treat a hereditary degenerative disorder.

September 13, 2012
FDA approves new MS drug

The Food and Drug Administration has approved a new drug for multiple sclerosis.

September 12, 2012
New, simplified HIV patient-assistance program application offered

Drug maker Johnson & Johnson said Wednesday that patients applying for its HIV drug assistance program would have a more streamlined application process.

September 7, 2012
BioPlus names IT VP

BioPlus announced that Fred Gagle has joined the company as VP information technology.

September 6, 2012
FDA advisory committee recommends approval for Novartis cystic fibrosis drug

A panel of Food and Drug Administration experts is recommending that the agency approve an experimental drug for cystic fibrosis made by Novartis, the Swiss drug maker said.

September 6, 2012
Walgreens, Ferring Pharmaceuticals offer products, educational materials to women with cancer

Walgreens will offer products and other resources for women who have fertility complications due to cancer treatment, under a partnership with Ferring Pharmaceuticals announced Thursday.

September 5, 2012
American BioTech Supply donates refrigerators to Denver Health

A safety-net healthcare organization in Colorado got a donation of four new vaccine refrigerators at the end of a recent trade show there.

September 5, 2012
Bayer, Onyx seek approval for gastrointestinal tumor drug

Bayer HealthCare and Onyx Pharmaceuticals are seeking approval for a new drug to treat tumors of the gut, the companies said.

September 5, 2012
FDA approves new drug for rare leukemia

The Food and Drug Administration has approved a new drug for treating a rare blood and marrow cancer that affects older adults, the agency said Tuesday.

© 2013 Drug Store News. All Rights Reserved.